Title | Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Shah S, Henry A, Roselli C, et al. |
Secondary Authors | R Lumbers T |
Corporate Authors | Regeneron Genetics Center |
Journal | Nat Commun |
Volume | 11 |
Issue | 1 |
Pagination | 163 |
Date Published | 2020 01 09 |
ISSN | 2041-1723 |
Keywords | Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Atrial Fibrillation, Cardiomyopathies, Carrier Proteins, Case-Control Studies, Coronary Artery Disease, Cyclin-Dependent Kinase Inhibitor p21, Genome-Wide Association Study, Heart Failure, Humans, Mendelian Randomization Analysis, Microfilament Proteins, Muscle Proteins, Risk Factors, Ventricular Function, Left |
Abstract | Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide association studies (GWAS) have yielded only limited insights, leaving the observed heritability of HF largely unexplained. We report results from a GWAS meta-analysis of HF comprising 47,309 cases and 930,014 controls. Twelve independent variants at 11 genomic loci are associated with HF, all of which demonstrate one or more associations with coronary artery disease (CAD), atrial fibrillation, or reduced left ventricular function, suggesting shared genetic aetiology. Functional analysis of non-CAD-associated loci implicate genes involved in cardiac development (MYOZ1, SYNPO2L), protein homoeostasis (BAG3), and cellular senescence (CDKN1A). Mendelian randomisation analysis supports causal roles for several HF risk factors, and demonstrates CAD-independent effects for atrial fibrillation, body mass index, and hypertension. These findings extend our knowledge of the pathways underlying HF and may inform new therapeutic strategies. |
DOI | 10.1038/s41467-019-13690-5 |
Alternate Journal | Nat Commun |
PubMed ID | 31919418 |
PubMed Central ID | PMC6952380 |
Grant List | RG/13/13/30194 / BHF_ / British Heart Foundation / United Kingdom MR/N003284/1 / MRC_ / Medical Research Council / United Kingdom 14136 / CRUK_ / Cancer Research UK / United Kingdom G0401527 / MRC_ / Medical Research Council / United Kingdom MR/K006584/1 / MRC_ / Medical Research Council / United Kingdom MC_PC_13040 / MRC_ / Medical Research Council / United Kingdom MR/S003754/1 / MRC_ / Medical Research Council / United Kingdom R01 HL139731 / HL / NHLBI NIH HHS / United States RG/18/13/33946 / BHF_ / British Heart Foundation / United Kingdom PCL/17/07 / CSO_ / Chief Scientist Office / United Kingdom MC_UU_12015/1 / MRC_ / Medical Research Council / United Kingdom RG/10/12/28456 / BHF_ / British Heart Foundation / United Kingdom SP/13/6/30554 / BHF_ / British Heart Foundation / United Kingdom |